The Phama Letter PharmaceuticalsPHARMACEUTICALS covers patent-protected prescription medicines, with news relating to drugmakers, their financial  performance, licensing, research and merger & acquisition activities. This also reports on health care markets, patent developments,  legislation, product approvals and delays around the globe, backed by a massive archive from which developments in all these areas can be tracked.

Latest Pharma Letter Articles

Pharmaceutical

features_upload

Access to medicines in Europe: the EU cannot save banks while sacrificing people's health

20 May 2013

In a seminar hosted last week by the Group of the Progressive Alliance of Socialists & Democrats

Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

20 May 2013

One of the most important preconditions for Turkey to reach a reformist, sustainable economic

HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst

20 May 2013

While the risks involved in HIV vaccine development have turned Big Pharma away from pursuing

Elan makes "transformational" acquisitions and a divestment

20 May 2013

Ireland-headquartered Elan Corp (NYSE: ELN) (Elan) this morning announced a series of transactions

Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines

20 May 2013

India's National Pharmaceutical Pricing Authority (NPPA) last week announced plans that will

SciClone gains China rights to Zensun's Neucardin

20 May 2013

USA-based SciClone Pharmaceuticals (Nasdaq: SCLN) today announced that the Company has entered